Oruka Therapeutics, Inc. (ORKA)
NASDAQ · Healthcare
$91.71-1.07%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $3.19B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,339,142
- 52-week high
- —
- 52-week low
- —
- Open
- $93.83
- Day high
- $96.27
- Day low
- $91.53
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$105.43M | — |
| 2024 | — | -$83.72M | -$3.87 |
| 2023 | $0 | -$5.34M | -$0.37 |
| 2022 | $0 | -$9.93M | -$0.69 |
| 2021 | $0 | -$19.32M | -$1.39 |
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.
- CEO
- Lawrence Otto Klein
- Employees
- 28
- Country
- US
- IPO date
- Aug 8, 1997
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Oruka Therapeutics, Inc.'s stock price today?
- ORKA is trading at $91.71 as of Jul 20, 2026.
- What is Oruka Therapeutics, Inc.'s market cap?
- Oruka Therapeutics, Inc. (ORKA) has a market capitalization of $3.19B.
- Does Oruka Therapeutics, Inc. pay a dividend?
- Oruka Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Oruka Therapeutics, Inc. in?
- Oruka Therapeutics, Inc. operates in the Healthcare sector.